MAT Act of 2026
- Sponsor
- Rep. McGuire, John J. [R-VA-5]
- Committees
- Judiciary Committee (primary)
- Last action
- Jul 16, 2026
Bottom line
The bill aims to improve health outcomes for pregnant women in federal custody and their children by ensuring access to evidence-based opioid addiction treatment, while preserving individual autonomy.
What it actually does
This bill mandates that the Director of the Bureau of Prisons (BOP) provide medication assisted treatment (MAT) for opioid addiction to all pregnant women in BOP custody who are addicted to opioids. It includes an explicit exception, allowing any mentally competent pregnant woman to decline the treatment.
Proponents argue
Supporters argue that providing MAT to pregnant women with opioid addiction is a medically sound approach that significantly improves health outcomes for both mothers and their babies, reducing the risk of complications like Neonatal Abstinence Syndrome. They contend it aligns federal correctional healthcare with best medical practices and addresses a critical public health issue within a vulnerable population.
Opponents contend
Critics might raise concerns about the potential administrative and financial burden on the Bureau of Prisons to implement and sustain such a program across all federal facilities, especially without specified funding. While the bill includes an opt-out, some may also express philosophical reservations about federal mandates concerning medical treatment, even for a vulnerable population.
The bill is exceptionally short and clear, allowing for quick comprehension and evaluation by any interested reader.
Section 2(a)
Mandatory Medication Assisted Treatment for Pregnant Women
This provision directs the Director of the Bureau of Prisons (BOP) to ensure that every pregnant woman in federal custody who is addicted to opioids receives medication assisted treatment (MAT). This mandate aims to provide a critical, evidence-based medical intervention for opioid use disorder to a highly vulnerable population.
Supporters argue
Proponents argue that this provision is essential for protecting the health and well-being of pregnant women and their unborn children, aligning federal prison healthcare with widely accepted medical standards for treating opioid use disorder during pregnancy. They emphasize that MAT is the gold standard for treatment and reduces harm.
Critics contend
Opponents, while generally not against treatment, might argue that mandating specific medical treatments could strain BOP resources without dedicated funding, potentially diverting funds from other necessary correctional services. They may also raise concerns about the practical challenges of implementing such a program consistently across diverse federal facilities.
Tradeoffs
The provision balances the critical need for evidence-based medical care for a vulnerable population against the operational and financial challenges of implementing such a program within a correctional system.
Section 2(b)
Right to Decline Treatment
This subsection establishes a clear exception to the mandatory treatment, stating that any pregnant woman who is mentally competent has the right to refuse the medication assisted treatment offered under the bill. This ensures that medical treatment is not forced upon individuals against their will, upholding principles of patient autonomy.